PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
3.50%
Revenue growth 50-75% of ORCL's 5.25%. Martin Whitman would scrutinize if slower growth is temporary.
-1.28%
Cost reduction while ORCL shows 0.00% growth. Joel Greenblatt would examine competitive advantage.
4.56%
Positive growth while ORCL shows decline. John Neff would investigate competitive advantages.
1.03%
Margin expansion while ORCL shows decline. John Neff would investigate competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
8.51%
Operating expenses change of 8.51% while ORCL maintains costs. Bruce Berkowitz would investigate control.
5.74%
Total costs change of 5.74% while ORCL maintains costs. Bruce Berkowitz would investigate control.
No Data
No Data available this quarter, please select a different quarter.
9.09%
D&A change of 9.09% while ORCL maintains D&A. Bruce Berkowitz would investigate efficiency.
0.34%
EBITDA growth while ORCL declines. John Neff would investigate advantages.
-4.46%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-0.56%
Both companies show declining income. Martin Whitman would check industry conditions.
-3.92%
Both companies show margin pressure. Martin Whitman would check industry conditions.
68.00%
Other expenses growth 50-75% of ORCL's 97.64%. Bruce Berkowitz would examine cost efficiency.
1.00%
Income change of 1.00% while ORCL is flat. Bruce Berkowitz would examine quality.
-2.41%
Pre-tax margin decline while ORCL shows 0.00% growth. Joel Greenblatt would examine position.
1.14%
Tax expense change of 1.14% while ORCL maintains burden. Bruce Berkowitz would investigate strategy.
0.94%
Income change of 0.94% while ORCL is flat. Bruce Berkowitz would examine quality.
-2.47%
Net margin decline while ORCL shows 0.00% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.94%
Share count reduction exceeding 1.5x ORCL's 2.41%. David Dodd would verify capital allocation.
0.94%
Diluted share reduction exceeding 1.5x ORCL's 2.41%. David Dodd would verify capital allocation.